Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Lynn StockwellCEO and Exe. Chair of Board | Open-market buy | 25/02/18 | 25/02/18 | 30,000 sh | In footnote | No stated value | +0.7% | |
Drugs Made In America Acquisition10% Owner | Open-market buy | 25/02/18 | 25/02/18 | 30,000 sh | In footnote | No stated value | +0.7% | |
Lynn StockwellCEO and Executive COB | Open-market buy | 25/01/29 | 25/02/04 | 400,000 sh | In footnote | No stated value | No record | |
Lynn StockwellCEO and Executive COB | Open-market sale | 25/01/29 | 25/02/04 | 5,698,363 sh | In footnote | No stated value | −57.8% | |
Drugs Made In America Acquisition10% Owner | Open-market buy | 25/01/29 | 25/02/04 | 400,000 sh | In footnote | No stated value | +4.1% | |
Drugs Made In America Acquisition10% Owner | Open-market sale | 25/01/29 | 25/02/04 | 5,698,363 sh | In footnote | No stated value | −57.8% |